These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2373198)

  • 41. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of subconjunctival liposome-encapsulated gentamicin in normal rabbit eyes.
    Barza M; Baum J; Szoka F
    Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):486-90. PubMed ID: 6706512
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative study between synthetic and phospholipids of natural origin: effect of phospholipid selection on the behavior of a topical liposomal dosage form incorporating terbinafine.
    Koutsoulas C; Suleiman E; Wagner A; Žabka M
    J Liposome Res; 2014 Dec; 24(4):336-43. PubMed ID: 24766655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
    Li N; Zhuang C; Wang M; Sun X; Nie S; Pan W
    Int J Pharm; 2009 Sep; 379(1):131-8. PubMed ID: 19559775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ocular bioavailability of ciprofloxacin in sustained release formulations.
    Ke TL; Cagle G; Schlech B; Lorenzetti OJ; Mattern J
    J Ocul Pharmacol Ther; 2001 Dec; 17(6):555-63. PubMed ID: 11777179
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
    Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
    Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ocular absorption of topically applied FK506 from liposomal and oil formulations in the rabbit eye.
    Pleyer U; Lutz S; Jusko WJ; Nguyen KD; Narawane M; Rückert D; Mondino BJ; Lee VH; Nguyen K
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2737-42. PubMed ID: 7688360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of bovine brain phospholipid exchange protein with liposomes of different lipid composition.
    Helmkamp GM
    Biochim Biophys Acta; 1980 Jan; 595(2):222-34. PubMed ID: 7352996
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition.
    Beaulac C; Clement-Major S; Hawari J; Lagace J
    J Microencapsul; 1997; 14(3):335-48. PubMed ID: 9147283
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does topical hydrogen peroxide penetrate the cornea?
    Wilson G; Riley MV
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2752-60. PubMed ID: 8344797
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of surface charge and density of distearylphosphatidylethanolamine-mPEG-2000 (DSPE-mPEG-2000) on the cytotoxicity of liposome-entrapped ricin: effect of lysosomotropic agents.
    Rathore SS; Ghosh PC
    Int J Pharm; 2008 Feb; 350(1-2):79-94. PubMed ID: 17913409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Covalent modification of serum transferrin with phospholipid and incorporation into liposomal membranes.
    Afzelius P; Demant EJ; Hansen GH; Jensen PB
    Biochim Biophys Acta; 1989 Feb; 979(2):231-8. PubMed ID: 2647146
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Free versus liposome-encapsulated lignocaine hydrochloride topical applications.
    el-Ridy MS; Khalil RM
    Pharmazie; 1999 Sep; 54(9):682-4. PubMed ID: 10522272
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis.
    Pawar VA; Manjappa AS; Murumkar PR; Gajaria TK; Devkar RV; Mishra AK; Yadav MR
    Eur J Pharm Sci; 2018 Dec; 125():11-22. PubMed ID: 30219410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preparation and lacrimal pharmacokinetics of eye drops of puerarin liposomes in rabbit tears].
    Deng Y; Xu J; Li X
    Zhongguo Zhong Yao Za Zhi; 2010 Feb; 35(3):301-4. PubMed ID: 20422993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Amphotericin B--bioavailability in the cornea. Studies with local administration of liposome incorporated amphotericin B].
    Pleyer U; Grammer J; Pleyer JH; Kosmidis P; Friess D; Schmidt KH; Thiel HJ
    Ophthalmologe; 1995 Aug; 92(4):469-75. PubMed ID: 7549331
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Membrane fusion activity of influenza virus. Effects of gangliosides and negatively charged phospholipids in target liposomes.
    Stegmann T; Nir S; Wilschut J
    Biochemistry; 1989 Feb; 28(4):1698-704. PubMed ID: 2719929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of liposome-encapsulated acyclovir with acyclovir ointment: ocular pharmacokinetics in rabbits.
    Chetoni P; Rossi S; Burgalassi S; Monti D; Mariotti S; Saettone MF
    J Ocul Pharmacol Ther; 2004 Apr; 20(2):169-77. PubMed ID: 15117573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Liposomal drug delivery to the eye and lungs: a preliminary electron microscopy study.
    Singh M; Meisner D; Faulkner G; Mezei M
    J Microencapsul; 1993; 10(1):35-44. PubMed ID: 8445506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.